Table. 1.
Patient characteristics within this study cohort
| No. | Age | Gender | Clinical TNM-stage | Imaging protocol | SUVmax tumour | Pathological TNM-stage | Tumour volume on PET (ml) | Tumour characterisation (with negative growth characteristics) |
|---|---|---|---|---|---|---|---|---|
| 1 | 69 | M | cT4aN0M0 | Whole body static | 6.5 | pT4aN2bM0 | 13 | Moderately differentiated SCC (discohesive growth pattern and perineural growth) |
| 2 | 74 | M | cT4aN0M0 | Whole body static | 7 | pT4aN1M0 | 20 | Moderately differentiated SCC |
| 3 | 71 | F | cT3N0M0 | Whole body static | 5.5 | pT4aN0M0 | 9 | Well-differentiated SCC |
| 4 | 65 | M | cT4aN0M0 | Whole body static | 4.7 | pT1N0M0 | 8 | Moderately differentiated SCC (discohesive growth pattern) |
| 5 | 63 | M | cT3N0M0 | Dynamic | 4 | pT2N0M0 | 8 | Moderately differentiated SCC |
| 6 | 80 | F | cT4aN1M0 | Dynamic* | 8.4 | pT4aN3bM0 | 25 | Moderately differentiated SCC (discohesive growth pattern) |
| 7 | 55 | M | cT3N1M0 | Dynamic | 12.7 | pT3N1M0 | 7 | Moderately differentiated SCC (perineural growth) |
| 8 | 37 | F | cT3N0M0 | Dynamic | 9.7 | pT2N3bM0 | 19 | Moderately differentiated SCC |
| 9 | 70 | M | cT3N0M0 | Dynamic | 6.8 | pT2N1M0 | 20 | Moderately differentiated SCC |
| 10 | 63 | M | cT3N0M0 | Dynamic | 9.4 | pT4aN2bM0 | 20 | Moderately differentiated SCC (discohesive growth pattern and perineural growth) |
*Patient that only underwent 30-min dynamic scanning